Sign inJoin waitlistJoin the waitlist

Madelyn Burkart

Internal Medicine Residency · Wake Forest University Baptist Medical Center

Credentials: · · ·

History

Internal Medicine
Wake Forest University Baptist Medical Center
2024–Present
Hematology and Medical Oncology
McGaw Medical Center of Northwestern University
2020–2023
Internal Medicine
Northwestern Universitys Feinberg School of Medicine
2016–2019
Wake Forest Univ Sch of Med
2012–2016

Research

Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis
Journal of Clinical Investigation · 2013 · 204 citations
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
Blood · 2021 · 94 citations
Structural racism is a mediator of disparities in acute myeloid leukemia outcomes
Blood · 2022 · 88 citations

Reem Karmali
16 papers
Anand Patel
15 papers · 3 as a fellow
RS
Rory Shallis
11 papers
Shira Dinner
11 papers
Talha Badar
11 papers · 2 as a fellow
David Bond
8 papers
Ehab Atallah
8 papers
Mark Litzow
8 papers
Narendranath Epperla
8 papers
AD
Alexey Danilov
7 papers
Kristie Blum
7 papers
Peter Martin
7 papers

Clinical trials

A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)
Principal investigator · Not yet recruiting · Phase 1
Wake Forest University Health Sciences
2026–2030
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Site PI · Recruiting · Phase 1
National Cancer Institute (NCI)
2025–2028
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2027